📷 Image: Wikimedia Commons / Original: Rohit Sharma
Derivative work: Unpetitp
Health
Revised MRP List Shows No Price Change for Non‑Scheduled Anti‑Cancer Drugs
✍️ LatestLY
🗓 29 Oct 2026, 05:38 PM
👁 18
The latest revision of the maximum retail price list indicates that prices for non‑scheduled anti‑cancer drug formulations remain unchanged.
The Ministry of Health and Family Welfare has published a revised maximum retail price (MRP) list for pharmaceutical products.
The updated list includes non‑scheduled anti‑cancer drug formulations, a category that had not been previously covered in earlier revisions.
According to the release, the prices for these formulations remain unchanged from the previous MRP schedule.
The unchanged pricing is expected to maintain affordability for patients while keeping the market stable.
The updated list includes non‑scheduled anti‑cancer drug formulations, a category that had not been previously covered in earlier revisions.
According to the release, the prices for these formulations remain unchanged from the previous MRP schedule.
The unchanged pricing is expected to maintain affordability for patients while keeping the market stable.